Drug Safety Podcasts > FDA Drug Safety Podcasts by Date

open here please:
Drug Safety Podcasts > FDA Drug Safety Podcasts by Date

FDA Drug Info has posted new Drug Safety Podcasts for Healthcare Professionals.  Click on the following links to read transcripts and listen to podcasts.

• Modified Risk Evaluation and Mitigation Strategies (REMS) for Nplate (romiplostim) and Promacta (eltrombopag) 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Modified Risk Evaluation and Mitigation Strategies (REMS) for Nplate (romiplostim) and Promacta (eltrombopag)
• Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate) 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate)
• Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
• Drug Safety Podcasts > FDA Drug Safety Podcasts for Healthcare Professionals: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
   
• Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
• Revised dose limitation for Zocor (simvastatin) when taken with amiodarone 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Revised dose limitation for Zocor (simvastatin) when taken with amiodarone
   
• Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events
• Safety review of a reported death after the first dose of Multiple Sclerosis drug Gilenya (fingolimod) 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Safety review of a reported death after the first dose of Multiple Sclerosis drug Gilenya (fingolimod)
• Addition of another concentration of liquid acetaminophen marketed for infants 
• Drug Safety Podcasts > FDA Drug Safety Podcast for Healthcare Professionals: Addition of another concentration of liquid acetaminophen marketed for infants
  
  You can download other Drug Safety Podcasts at: FDA Drug Safety Podcasts or subscribe to the Drug Safety Podcasts channel in iTunes at: Drug Safety Podcasts
• iTunes - Podcasts - Food and Drug Administration Drug Safety Podcast by U.S. Food and Drug Administration, Center for Drug Evaluation and Research